James E. Gardner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
James E. Gardner has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Austin J. Sturdivant
Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, USA
1 shared publicationDevon T. Shannon
Department of Orthopaedics, Emory University School of Medicine, Atlanta, USA
1 shared publication- Eric R. Wagner
Emory University, Atlanta, GA, USA
1 shared publication - Farah S. Hussain
Department of Orthopaedics and Rehabilitation Medicine, University of Chicago, Chicago, Ilinois
1 shared publication Kirk A. Easley
Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia; and
1 shared publication- Robert L. Bowers
Department of Orthopaedics Emory University School of Medicine Atlanta Georgia USA
1 shared publication
Latest Publications
- 24 August 2026
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
Ultrasound-Guided Diagnostic Injections for Neurogenic Thoracic Outlet Syndrome: An Outcomes-Based Cohort Study
Objective: Neurogenic thoracic outlet syndrome (NTOS) is an underrecognized problem causing chronic upper extremity symptoms from brachial plexus compression, often affecting overhead athletes. This study evaluated the utility of ultrasound-guided (USG) diagnostic injections for NTOS. Design: This was a retrospective chart review. Setting: This study was conducted at a single institution. Patients: In total, 203 patients (121 female, 81 male, and 1 nonbinary) with suspected NTOS underwent USG diagnostic blocks. Forty-five were athletes, including 42 overhead athletes. Intervention: A single sports medicine physician performed USG diagnostic injections targeting the pectoralis minor (PM), anterior and middle scalenes, suprascapular nerve (SSN), or quadrilateral space. Main Outcome Measures: Patients reported symptomatic relief >50%. Results: PM blocks were positive in 125/186 (67%) cases and scalene blocks in 85/130 (65%). SSN and quadrilateral space blocks were positive in 34/76 (44%) and 4/11 (36%), respectively. Among 95 nonathletes receiving both PM and scalene blocks, greatest relief was reported with scalene in 40 (42%) and PM in 31 (32.6%), 8 (8.4%) improved with both, 10 (10.5%) with neither, and 6 unreported (6.3%). Among athletes, 36/42 (85.7%) had positive PM blocks and 13/20 (65%) had positive scalene blocks. SSN and quadrilateral space blocks were positive in 9/14 (64%) and 1/3 (33%), respectively. Of 22 athletes receiving both PM and scalene blocks, 16 (73%) reported greatest relief with PM, 4 (18%) with scalene, and 2 (9%) with neither. Conclusions: PM blocks produced symptom relief comparable with scalene blocks in the general population and were the most effective diagnostic injection in athletes. These results suggest the PM is a more prominent symptom generator in NTOS than previously recognized, particularly in athletes.
- 24 August 2026
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
Ultrasound-Guided Diagnostic Injections for Neurogenic Thoracic Outlet Syndrome: An Outcomes-Based Cohort Study
Objective: Neurogenic thoracic outlet syndrome (NTOS) is an underrecognized problem causing chronic upper extremity symptoms from brachial plexus compression, often affecting overhead athletes. This study evaluated the utility of ultrasound-guided (USG) diagnostic injections for NTOS. Design: This was a retrospective chart review. Setting: This study was conducted at a single institution. Patients: In total, 203 patients (121 female, 81 male, and 1 nonbinary) with suspected NTOS underwent USG diagnostic blocks. Forty-five were athletes, including 42 overhead athletes. Intervention: A single sports medicine physician performed USG diagnostic injections targeting the pectoralis minor (PM), anterior and middle scalenes, suprascapular nerve (SSN), or quadrilateral space. Main Outcome Measures: Patients reported symptomatic relief >50%. Results: PM blocks were positive in 125/186 (67%) cases and scalene blocks in 85/130 (65%). SSN and quadrilateral space blocks were positive in 34/76 (44%) and 4/11 (36%), respectively. Among 95 nonathletes receiving both PM and scalene blocks, greatest relief was reported with scalene in 40 (42%) and PM in 31 (32.6%), 8 (8.4%) improved with both, 10 (10.5%) with neither, and 6 unreported (6.3%). Among athletes, 36/42 (85.7%) had positive PM blocks and 13/20 (65%) had positive scalene blocks. SSN and quadrilateral space blocks were positive in 9/14 (64%) and 1/3 (33%), respectively. Of 22 athletes receiving both PM and scalene blocks, 16 (73%) reported greatest relief with PM, 4 (18%) with scalene, and 2 (9%) with neither. Conclusions: PM blocks produced symptom relief comparable with scalene blocks in the general population and were the most effective diagnostic injection in athletes. These results suggest the PM is a more prominent symptom generator in NTOS than previously recognized, particularly in athletes.
- 15 December 2025
- Published by Springer Nature in Current Physical Medicine and Rehabilitation Reports
- Vol. 13 (1) , 52
Orthobiologic Treatments for Tendinopathy
- 15 December 2025
- Published by Springer Nature in Current Physical Medicine and Rehabilitation Reports
- Vol. 13 (1) , 52
Orthobiologic Treatments for Tendinopathy